株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の糖尿病市場

Global Diabetes Devices Market: Industry Analysis & Outlook 2017-2021

発行 Koncept Analytics 商品コード 223069
出版日 ページ情報 英文 87 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=112.46円で換算しております。
Back to Top
世界の糖尿病市場 Global Diabetes Devices Market: Industry Analysis & Outlook 2017-2021
出版日: 2017年09月16日 ページ情報: 英文 87 Pages
概要

当レポートでは、世界の糖尿病市場について調査分析し、市場の動向と発展、成長促進要因と課題、競合情勢、主要企業プロファイルなど、体系的な情報を提供しています。

第1章 糖尿病について

第2章 世界の糖尿病市場

  • 糖尿病人口
  • 有病率
  • 治療市場規模
  • インスリン市場規模
  • インスリンセグメント
  • 内訳:地域別

第3章 糖尿病治療市場

  • 世界の糖尿病ケア市場:治療クラス別
  • 世界のインスリン市場:セグメント別
  • 世界のインスリン市場:地域別
  • 世界のインスリン使用者:地域別
  • 世界の注射型糖尿病治療薬の売上額
  • 世界の注射型糖尿病治療薬の売上額予測

第4章 地域別分析

  • 西太平洋
  • 東南アジア
  • 欧州
  • 北米・カリブ海
  • 中東・北アフリカ
  • 中南米
  • アフリカ

第5章 市場力学

  • 成長促進要因
  • 市場動向
  • 課題

第6章 競合情勢

  • 世界市場
  • 地域別
    • 米国
    • 欧州
    • 中国
    • 日本

第7章 企業プロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Diabetes, referred to as diabetes mellitus by doctors, is a group of metabolic disorders which abnormally affect the level of sugar (glucose) in blood. Diabetes can either be due to pancreas not producing enough insulin or irresponsiveness of cells of the body to insulin. Insulin is a hormone which regulates the metabolism of carbohydrates, fat and protein by absorbing glucose (sugar) from the blood into fat, liver and skeletal muscles.

Diabetes devices are used in managing and treating diabetes and the market is filled with a vast variety of these devices. These devices can be broadly classified into two categories that include glucose monitoring and insulin pumps. Glucose monitoring devices are further divided into two type: traditional glucose monitoring and continuous glucose monitoring.

The U.S. is a major contributor to the global diabetes device market supported by increased ageing and obese population, better accessibility and favorable reimbursement policies for continuous glucose monitoring systems.

Continuous glucose monitoring was the most significant segment in the growth of global diabetes device market due to technological improvements in monitoring systems and increased recommendations by doctors. This segment is likely to witness a notable growth in future as well.

The global diabetes device market is expected to grow in future with increasing ageing population, obese population, rising spending on diabetes treatment, expanding patient pool suffering from diabetes, increasing disposable income and growing urbanization. Key trends of this market include increasing awareness towards diabetes devices, rising innovations in diabetes devices and adoption of sedentary lifestyle. However, there are some factors which can hinder the market growth including stringent legal norms, high costs and alternative treatments.

The report “Global Diabetes Devices Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., and Europe region along with the global market. The report profiles the key players of the market including Johnson & Johnson, Medtronic plc, Abbott Laboratories and DexCom Inc.

Table of Contents

1. Overview

  • 1.1. Diabetes
  • 1.2. Symptoms of Diabetes
  • 1.3. Diagnosis of Diabetes
  • 1.4. Diabetes Management
  • 1.5. Diabetes Devices

2. Global Diabetes Devices Market

  • 2.1. Diabetes Devices Market Value Forecast
  • 2.2. Diabetes Devices Market by Type
    • 2.2.1. Global Glucose Monitoring Devices Market by Value
    • 2.2.2. Global Glucose Monitoring Devices Market Value Forecast
    • 2.2.3. Global Traditional Glucose Monitoring Market by Value
    • 2.2.4. Global Traditional Glucose Monitoring Market Value Forecast
    • 2.2.5. Global Continuous Glucose Monitoring Market by Value
    • 2.2.6. Global Continuous Glucose Monitoring Market Value Forecast
    • 2.2.7. Global Insulin Pumps Market Value Forecast

3. Regional Market

  • 3.1. The U.S.
    • 3.1.1. The U.S. Diabetic Population
    • 3.1.2. The U.S. Diabetic Population Forecast
    • 3.1.3. The U.S. Diagnosed Diabetic Population
    • 3.1.4. The U.S. Diagnosed Diabetic Population Forecast
    • 3.1.5. The U.S. Diagnosed Diabetic Population by Type
    • 3.1.6. The U.S. Continuous Glucose Monitoring Market Forecast
    • 3.1.7. The U.S. CGM Type 1 Market by Volume
    • 3.1.8. The U.S. CGM Type 1 Market Volume Forecast
    • 3.1.9. The U.S. CGM Type 1 Market Volume by Patient Type
    • 3.1.10. The U.S. CGM Type 1 Market Volume Forecast by Type
    • 3.1.11. The U.S. Insulin Pump Market by Volume
    • 3.1.12. The U.S. Insulin Pump Market Volume Forecast
  • 3.2. Europe
    • 3.2.1. Europe Diabetic Population
    • 3.2.2. Europe Diabetic Population Forecast
    • 3.2.3. Europe Diabetic Population by Type
    • 3.2.4. Europe CGM Type 1 Market by Volume
    • 3.2.5. Europe CGM Type 1 Market Volume Forecast

4. Market Dynamics

  • 4.1. Growth Drivers
    • 4.1.1. Expanding Patient Pool Suffering from Diabetes
    • 4.1.2. Increasing Ageing Population
    • 4.1.3. Mounting Obese Population
    • 4.1.4. Increasing Life Expectancy
    • 4.1.5. Growing Spending on Diabetes Treatment
    • 4.1.6. Rising Urbanization
    • 4.1.7. Increasing Disposable Income
  • 4.2. Key Trends & Developments
    • 4.2.1. Increasing Awareness
    • 4.2.2. Increasing Innovation in Diabetes Devices
    • 4.2.3. Sedentary Lifestyle
  • 4.3. Challenges
    • 4.3.1. Stringent Legal Norms
    • 4.3.2. High Cost and Alternative Treatments

5. Competitive Landscape

  • 5.1. Global Market
    • 5.1.1. Revenue Comparison of Key Players
    • 5.1.2 Market Cap of Key Players
    • 5.1.3. Global CGM Market Share by Company
  • 5.2. The U.S.
    • 5.2.1. The U.S. CGM Market Volume Share by Company
    • 5.2.2. The U.S. CGM Type 1 Market Volume Share by Company
    • 5.2.3. The U.S. Insulin Pump Market Volume Share by Company

6. Company Profiles

  • 6.1. Johnson & Johnson
    • 6.1.1. Business Overview
    • 6.1.2. Financial Overview
    • 6.1.3. Business Strategies
  • 6.2. Medtronic Plc
    • 6.2.1. Business Overview
    • 6.2.2. Financial Overview
    • 6.2.3. Business Strategies
  • 6.3. Abbott Laboratories
    • 6.3.1. Business Overview
    • 6.3.2. Financial Overview
    • 6.3.3. Business Strategies
  • 6.4. DexCom, Inc.
    • 6.4.1. Business Overview
    • 6.4.2. Financial Overview
    • 6.4.3. Business Strategies

List of Charts

  • Type of Diabetes
  • Symptoms of Diabetes
  • Types of Diabetes Device
  • Global Diabetes Devices Market Value Forecast (2016-2021)
  • Global Diabetes Devices Market by Type (2016/2021)
  • Global Glucose Monitoring Devices Market by Value (2012-2016)
  • Global Glucose Monitoring Devices Market Value Forecast (2017-2021)
  • Global Traditional Glucose Monitoring Market by Value (2012-2016)
  • Global Traditional Glucose Monitoring Market Value Forecast (2017-2021)
  • Global Continuous Glucose Monitoring Market by Value (2012-2016)
  • Global Continuous Glucose Monitoring Market Value Forecast (2017-2021)
  • Global Insulin Pumps Market Value Forecast (2016-2021)
  • The U.S. Diabetic Population (2013-2016)
  • The U.S. Diabetic Population Forecast (2017-2021)
  • The U.S. Diagnosed Diabetic Population (2013-2016)
  • The U.S. Diagnosed Diabetic Population Forecast (2017-2021)
  • The U.S. Diagnosed Diabetic Population by Type (2016)
  • The U.S. Continuous Glucose Monitoring Market Forecast (2016-2021)
  • The U.S. CGM Type 1 Market by Volume (2013-2016)
  • The U.S. CGM Type 1 Market Volume Forecast (2017-2021)
  • The U.S. CGM Type 1 Market Volume by Patient Type (2013-2016)
  • The U.S. CGM Type 1 Market Volume Forecast by Type (2017-2021)
  • The U.S. Insulin Pump Market by Volume (2013-2016)
  • The U.S. Insulin Pump Market Volume Forecast (2017-2021)
  • Europe Diabetic Population (2013-2016)
  • Europe Diabetic Population Forecast (2017-2021)
  • Europe Diabetic Population by Type (2016)
  • Europe CGM Type 1 Market by Volume (2013-2016)
  • Europe CGM Type 1 Market Volume Forecast (2017-2021)
  • Global Diabetic Prevalence (2015/2040E)
  • Global Ageing Population (2012-2016)
  • Global Obese Population (2012-2016)
  • Global Life Expectancy at Birth (2012-2016)
  • Global Spending on Diabetes Treatment (2015/2040 E)
  • Global Urban Population (2012-2016)
  • Global GNI per Capita (2012-2016)
  • Revenue Comparison of Key Players (2016)
  • Market Cap Comparison of Key Players (2016)
  • Global CGM Market Share by Company (2016/2021)
  • The U.S. CGM Market Volume Share by Company (2016/2021)
  • The U.S. CGM Type 1 Market Volume Share by Company (2016/2021)
  • The U.S. Insulin Pump Market Volume Share by Company (2016/2021)
  • Johnson & Johnson Revenue by Product Segment (2016)
  • Johnson & Johnson Revenue and Net Earnings (2012-2016)
  • Johnson & Johnson Research and Development Expenditure (2013-2016)
  • Medtronic Plc Sales by Segment (2017*)
  • Medtronic Plc Net Sales and Net Earnings (2012-2017*)
  • Medtronic R&D Expenditure (2015-2017*)
  • Abbott Laboratories Sales by Segment (2016)
  • Abbott Laboratories Net Sales and Net Earnings (2012-2016)
  • Abbott Laboratories R&D Expenditure (2014-2016)
  • DexCom Revenue by Region (2016)
  • DexCom Inc. Total Revenue and Net Loss (2012-2016)
  • DexCom Inc. R&D Expenditure (2014-2016)
Back to Top